መነሻ › የኮሎሬክታል ካንሰር › North Carolina › Durham
በDurham፣ NC ለየኮሎሬክታል ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየኮሎሬክታል ካንሰር የሚደረጉ 28 ጥናቶች በDurham እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
The Vanguard Study: Testing a New Way to Screen for Cancer
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ማይል ርቀት
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Duke University Medical Center /ID# 279322, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Durham VA Medical Center, Durham
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Exelixis Clinical Site #12, Durham
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- Duke University Hospital - Vascular Interventional Radiology, Durham
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke Cancer Center, Durham
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of North Carolina Medical Center /ID# 267786, Chapel Hill · 10 ማይል ርቀት
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ማይል ርቀት
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Duke University Medical Center, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Duke University Medical Center, Durham
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University Medical Center, Durham
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University School of Medicine, Durham
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- The University of North Carolina At Chapel Hill, Chapel Hill · 10 ማይል ርቀት
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Duke Cancer Center, Durham
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Duke University Medical Center, Durham
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center - Duke Cancer Center, Durham
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University, Durham
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- GSK Investigational Site, Durham
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Duke Cancer Center, Durham
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Duke University Hospital, Durham
- Duke University Medical Center, Duke Cancer Center, Durham
- Duke University Medical Center, Durham
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center, Durham
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
ተሳታዮችን በመፈለግ ላይ
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 ማይል ርቀት
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Duke University Medical Center /ID# 279457, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Research Site, Durham
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Duke University Medical Center, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Duke Cancer Center, Durham
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
ተሳታዮችን በመፈለግ ላይ
- Duke Cancer Institute, Durham
በሌሎች ከተሞች ለየኮሎሬክታል ካንሰር የሚደረጉ ጥናቶች
- Houston, TX102 ጥናቶች
- New York City, NY78 ጥናቶች
- Nashville, TN69 ጥናቶች
- Boston, MA63 ጥናቶች
- Los Angeles, CA59 ጥናቶች
- Arlington, VA52 ጥናቶች
- St. Louis, MO50 ጥናቶች
- San Antonio, TX46 ጥናቶች
- Philadelphia, PA44 ጥናቶች
- Grand Rapids, MI40 ጥናቶች
- Baldwin Park, CA37 ጥናቶች
- Chicago, IL34 ጥናቶች
በDurham ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር64 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)58 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር39 ጥናቶች
- Multiple Myeloma37 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ33 ጥናቶች
- Metastatic Cancer33 ጥናቶች
- የፕሮስቴት ካንሰር32 ጥናቶች
- የሳንባ ካንሰር32 ጥናቶች
- የእንቁላል ካንሰር27 ጥናቶች
- ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ27 ጥናቶች
- የልብ ድካም26 ጥናቶች
- የፓንክሪያስ ካንሰር24 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።